Erythrocyte aggregation and metabolic syndrome

Area of Science:

• Hematology
• Cardiovascular Physiology
• Metabolic Disorders

Background:

• Erythrocyte aggregation is linked to insulin resistance, obesity, and hypertension.
• Metabolic syndrome (MetS) involves oxidative stress and chronic inflammation.
• These factors alter red blood cell (RBC) properties and increase blood viscosity.

Purpose of the Study:

• To explore the relationship between erythrocyte aggregation and MetS.
• To investigate the role of oxidative stress, inflammation, and rheological factors in MetS.
• To highlight the need for further research into the hemodynamic aspects of MetS.

Main Methods:

• Literature review associating erythrocyte aggregation with MetS components.
• Discussion of how MetS-related factors (prooxidants, adipocytokines) affect RBC morphology and deformability.
• Analysis of whole blood viscosity (WBV) and its relation to erythrocyte aggregation.

Main Results:

• Increased WBV in MetS is attributed to erythrocyte aggregation.
• Erythrocyte aggregation is influenced by membrane surface charge and fibrinogen levels.
• The interplay of hemorheology, oxidative stress, and inflammation detrimentally affects microcirculation in MetS.

Conclusions:

• Disturbances in hemorheology, oxidative stress, and inflammation significantly impact MetS.
• MetS involves complex interactions affecting blood flow and microcirculation.
• Further research on the hemodynamic aspects of MetS is warranted.